Brief: Kymera Therapeutics Announces Pricing Of $250 Million Public Offering
27/06/2025 04:57
June 26 (Reuters) - Kymera Therapeutics Inc KYMR.O: KYMERA THERAPEUTICS ANNOUNCES PRICING OF $250 MILLION PUBLIC OFFERING KYMERA THERAPEUTICS INC - KYMERIA THERAPEUTICS PRICES $250.8 MILLION PUBLIC OFFERING KYMERA THERAPEUTICS INC - COMMON STOCK PRICED AT $44.00 PER SHARE, PRE-FUNDED WARRANTS AT $43.9999 Source text: ID:nGNX85RWfv Further company coverage: KYMR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kymera Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Adobe, Dell Technologies, Zscaler
Kymera Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kymera Therapeutics Q2 collaboration revenue more than doubles, beats estimates
Brief: Kymera Therapeutics Q2 EPS USD -0.62
Brief: Kymera Therapeutics Appoints Terence Rooney, MD, As Chief Medical Officer